Postischemic therapy with MK-801 (dizocilpine) in a primate model of transient focal brain ischemia

Molecular and Chemical Neuropathology

Volumn 29, Issue 2-3, 1996, Pages 193-210

  Auer, Roland N ^a   Coupland, Stuart G ^a   Jason, Gregor W ^a   Archer, David P ^a   Payne, Jacqueline ^a   Belzberg, Alan J ^a   Ohtaki, Masefumi ^a   Tranmer, Bruce I ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

brain; channel blocker; focal; glutamate; Ischemia; necrosis; NMDA antagonist; primate; transient

Indexed keywords

DIZOCILPINE; HALOTHANE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN PROTECTION; CINGULATE GYRUS; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; INTRAVENOUS DRUG ADMINISTRATION; MEMORY; MIDDLE CEREBRAL ARTERY OCCLUSION; MONKEY; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK;

EID: 0030477899     PISSN: 10447393     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02815002     Document Type: Article

References (14)

1. Auer R. N. (1996) Effect of age and sex on NMDA antagonist-induced neuronal necrosis. Stroke 27, 743-746.
2. Auer R. N. and Coulter K. C. (1994) The nature and time course of neuronal vacuolation induced by the NMDA antagonist MK-801. Acta Neuropathol. (Berl.) 87, 1-7.
3. Auer R. N. and Siesjö B. K. (1988) Biological differences between ischemia, hypoglycemia, and epilepsy. Ann. Neurol. 24, 699-707.
4. Auer R. N., Ingvar M., Nevander G.; Olsson Y., and Siesjo B. K. (1986) Early axonal lesion and preserved microvasculature in epilepsy-induced hypermetabolic necrosis of the substantia nigra. Acta Neuropathol (Berl.) 71, 207-215.
5. Benveniste H., Drejer J., Schousboe A., and Diemer N. H. (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374.
6. Bielenberg G. W. and Beck T. (1991) The effects of dizocilpine (MK-801), phencyclidine, and nimodipine on infarct size 48 h after middle cerebral artery occlusion in the rat. Brain Res. 552, 338-342.
7. Boxer P. A., Cordon J. J., Mann M. E., Rodolosi L. C., Vartanian M. G., Rock D. M., Taylor C. P., and Marcoux F. W. (1990) Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat. Stroke 21(11 Suppl), 11147-51.
8. Buchan A. M. (1992) Do NMDA antagonists prevent neuronal injury? No. Arch. Neurol. 49, 420-421.
9. Buchan A. and Pulsinelli W. A. (1990) Hypothermia but not the N-methyl-d-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J. Neurosci. 10, 311-3316.
10. Buchan A., Li H., and Pulsinelli W. A. (1991) The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. J. Neurosci 11, 1049-1056.
11. Buchan A. M., Slivka A., and Xue D. (1992) The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Res. 574, 171-177.
12. Clow D. W., Lee S; J., and Hammer R. P., Jr. (1991) Competitive (AP7) and noncompetitive (MK-801)-NMDA receptor antagonists differentially alter glucose utilization in rat cortex. Synapse 7, 260-268.
13. Corbett D., Evans S., Thomas C., Wang D., and Jonas R. (1990) MK-801 reduces cerebral ischemic injury by inducing hypothermia. Brain Res. 514, 300-304.
14. Dezsi L., Greenberg J. H., Sladky J., Araki N., Hamar J., and Reivich M. (1994) Prolonged effects of MK-801 in the cat during focal cerebral ischemia and recovery: survival, EEG activity and histopathology. J. Neurol. Sci. 121, 110-120.